drugset / Trial / NCT02746926
A Study Comparing Amounts of Tafamidis (PF-06291826) in the Blood Without Food in Healthy Volunteers
RandomizedCrossoverOpen-labelBasic science
Summary
3 different formulations and doses of tafamidis will be compared. Subjects will be fasted for each test and every subject will test all 3 different formulations. After swallowing tafamidis, tafamidis blood concentrations will be measured periodically for 8 days. After 14 days, subjects will take a different formulation of tafamidis and tafamidis blood concentrations will be measured periodically for 8 days. After another 14 days, the last formulation will be tested in the same way.
Timeline
- Start
- 2016-04-29
- Primary completion
- 2016-07-15
- Completion
- 2016-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tafamidis | Unknown | 48.8 mg | Oral |
| Subject | Tafamidis | Unknown | 61 mg | Oral |
| Subject | Tafamidis | Unknown | 80 mg | Oral |
Indications
No indication recorded.